| scholarly article | Q13442814 |
| P2093 | author name string | Yan Li | |
| Jingdong Li | |||
| Wanling Wang | |||
| Youmei Zi | |||
| P2860 | cites work | A Pituitary-Derived MEG3 Isoform Functions as a Growth Suppressor in Tumor Cells | Q24299283 |
| Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions | Q24623420 | ||
| TET2 and MEG3 promoter methylation is associated with acute myeloid leukemia in a Hainan population | Q33566938 | ||
| Upregulation of the lncRNA Meg3 induces autophagy to inhibit tumorigenesis and progression of epithelial ovarian carcinoma by regulating activity of ATG3. | Q33761884 | ||
| Identification of an imprinted gene, Meg3/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q. | Q33897694 | ||
| Upregulation of long noncoding RNA MIAT in aggressive form of chronic lymphocytic leukemias | Q34537413 | ||
| microRNA-184 functions as tumor suppressor in renal cell carcinoma | Q35048683 | ||
| BCR-ABL1 mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phase | Q36026747 | ||
| β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia. | Q36362945 | ||
| DIANA-LncBase: experimentally verified and computationally predicted microRNA targets on long non-coding RNAs | Q36491490 | ||
| A Multi-centric Bioequivalence Trial in Ph+ Chronic Myeloid Leukemia Patients to Assess Bioequivalence and Safety Evaluation of Generic Imatinib Mesylate 400 mg Tablets | Q37097538 | ||
| Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management | Q38204330 | ||
| The MMP-1, MMP-2, and MMP-9 gene polymorphisms and susceptibility to bladder cancer: a meta-analysis | Q38665279 | ||
| Long noncoding RNA HULC promotes cell proliferation by regulating PI3K/AKT signaling pathway in chronic myeloid leukemia | Q38722244 | ||
| The significance of microRNA-184 on JAK2/STAT3 signaling pathway in the formation mechanism of glioblastoma | Q38801455 | ||
| Expression and functional perspectives of miR-184 in pancreatic ductal adenocarcinoma | Q38807225 | ||
| Long non-coding RNA HOTAIR modulates c-KIT expression through sponging miR-193a in acute myeloid leukemia | Q38874356 | ||
| Dual inhibition of Bcr-Abl and Hsp90 by C086 potently inhibits the proliferation of imatinib-resistant CML cells | Q38929308 | ||
| Antimetastatic effects of licochalcone B on human bladder carcinoma T24 by inhibition of matrix metalloproteinases-9 and NF-кB activity. | Q38968280 | ||
| Gallic acid inhibits migration and invasion of SCC-4 human oral cancer cells through actions of NF-κB, Ras and matrix metalloproteinase-2 and -9. | Q38991803 | ||
| Daidzein, R-(+)equol and S-(-)equol inhibit the invasion of MDA-MB-231 breast cancer cells potentially via the down-regulation of matrix metalloproteinase-2. | Q39169173 | ||
| Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation | Q39414139 | ||
| The mechanism of adenosine-mediated activation of lncRNA MEG3 and its antitumor effects in human hepatoma cells | Q40231569 | ||
| Second generation tyrosine kinase inhibitors prevent disease progression in high-risk (high CIP2A) chronic myeloid leukaemia patients. | Q41234743 | ||
| miR-184 functions as an oncogenic regulator in hepatocellular carcinoma (HCC). | Q43711053 | ||
| Long non-coding RNA MEG3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis | Q43957803 | ||
| Dysfunction of the WT1-MEG3 signaling promotes AML leukemogenesis via p53-dependent and -independent pathways. | Q50043003 | ||
| lncRNA MEG3 had anti-cancer effects to suppress pancreatic cancer activity. | Q51093479 | ||
| Involvement of endoplasmic reticulum stress and p53 in lncRNA MEG3-induced human hepatoma HepG2 cell apoptosis. | Q51632007 | ||
| Mechanisms of resistance in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors. | Q53220726 | ||
| P433 | issue | 2 | |
| P921 | main subject | leukemia | Q29496 |
| chronic myeloid leukemia | Q729735 | ||
| P304 | page(s) | 297-305 | |
| P577 | publication date | 2017-06-22 | |
| P1433 | published in | Oncology Research | Q15750114 |
| P1476 | title | Long Noncoding RNA MEG3 Inhibits Cell Proliferation and Metastasis in Chronic Myeloid Leukemia via Targeting miR-184. | |
| P478 | volume | 26 |
| Q64086187 | Increased methylation upstream of the MEG3 promotor is observed in acute myeloid leukemia patients with better overall survival |
| Q64069698 | Knockdown of lncRNA-UCA1 inhibits the proliferation and migration of melanoma cells through modulating the miR-28-5p/HOXB3 axis |
| Q91940399 | LncRNA SOX2 overlapping transcript acts as a miRNA sponge to promote the proliferation and invasion of Ewing's sarcoma |
| Q55284142 | Long non-coding RNA GAS5 inhibits ovarian cancer cell proliferation via the control of microRNA-21 and SPRY2 expression. |
| Q60927194 | Long non-coding RNA XIST serves an oncogenic role in osteosarcoma by sponging miR-137 |
| Q59329575 | Long non-coding RNAs in hematological malignancies: translating basic techniques into diagnostic and therapeutic strategies |
| Q55050306 | MEG3 Activated by Vitamin D Inhibits Colorectal Cancer Cells Proliferation and Migration via Regulating Clusterin. |
| Q42700665 | Potential applications of MEG3 in cancer diagnosis and prognosis |
| Q61984904 | Retracted: Long Noncoding RNA SOX2OT Accelerates the Carcinogenesis of Wilms' Tumor Through ceRNA Through miR-363/FOXP4 Axis |
| Q55310260 | lncRNA-MEG3 Suppresses the Proliferation and Invasion of Melanoma by Regulating CYLD Expression Mediated by Sponging miR-499-5p. |
Search more.